- Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective study.Zang, Mengya; Li, Qi; Hu, Xiaoyun; Yuan, Guosheng; Li, Rong; Guo, Yabing; Chen, JinzhangAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 1
- Comparison of liver injury after transcatheter arterial chemoembolization and hepatic arterial infusion chemotherapy for intermediate and advanced hepatocellular carcinomaLi, R.; Li, W.; Yuan, G.; Li, Q.; Hu, X.; Zhu, P.; Chen, Y.; Su, K.; Guo, Y.; Zang, M.; Chen, J.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
- TACE combined with apatinib in patients with intermediate and advanced hepatocellular carcionma: A prospective, multi-center, randomized clinical trialLiang, B.; Ma, Y.; Huang, M.; Zhang, X.; Yu, L.; Luo, Y.; Liu, R.; Zhou, S.; Xu, G.; Li, H-L.; Liao, Z.; Xiang, H.; Lu, W.; Xu, L.; Zheng, C.ESMO Asia Congress, Singapore, SINGAPORE, 2022-12-02 To 2022-12-04.
会议论文
Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial
2被引12阅读
